Design and optimization of a multiplex anti-influenza peptide immunoassay

Journal of Immunological Methods

Volumn 334, Issue 1-2, 2008, Pages 11-20

  Drummond, James E ^a   Shaw, Eric E ^a   Antonello, Joseph M ^a   Green, Tina ^a   Page, Gerald J ^a   Motley, Cliff O ^a   Wilson, Keith A ^a   Finnefrock, Adam C ^a   Liang, Xiaoping ^a   Casimiro, Danilo R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

EIA peptide vaccine; Influenza; Multiplex

Indexed keywords

AVIDIN; BIOTIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MICROSPHERE; PEPTIDE VACCINE; PROTEIN M2;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; INFANT; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOASSAY; INFANT; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; MACACA MULATTA; MALE; PEPTIDES; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS;

FLU VACCINE; MACACA MULATTA;

EID: 41949128506     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.01.017     Document Type: Article

References (16)

1. Ansaldi F., Bacilieri S., Amicizia D., Valle L., Banfi F., Durando P., Sticchi L., Gasparini R., Icardi G., and Crovari P. Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis. J. Med. Virol. 74 (2004) 141
2. Bianchi E., Liang X., Ingallinella P., Finotto M., Chastain M.A., Fan J., Fu T.M., Song H.C., Horton M.S., Freed D.C., Manger W., Wen E., Shi L., Ionescu R., Price C., Wenger M., Emini E.A., Cortese R., Ciliberto G., Shiver J.W., and Pessi A. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. J. Virol. 79 (2005) 7380
3. de Jong J.C., Beyer W.E., Palache A.M., Rimmelzwaan G.F., and Osterhaus A.D. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J. Med. Virol. 61 (2000) 94
4. Dias D., Van Doren J., Schlottmann S., Kelly S., Puchalski D., Ruiz W., Boerckel P., Kessler J., Antonello J.M., Green T., Brown M., Smith J., Chirmule N., Barr E., Jansen K.U., and Esser M.T. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin. Diagn. Lab. Immunol. 12 (2005) 959
5. Draper N.R., and Smith H. Applied Regression Analysis (1986), John Wiley & Sons, Inc., New York
6. Fan J., Liang X., Horton M.S., Perry H.C., Citron M.P., Heidecker G.J., Fu T.M., Joyce J., Przysiecki C.T., Keller P.M., Garsky V.M., Ionescu R., Rippeon Y., Shi L., Chastain M.A., Condra J.H., Davies M.E., Liao J., Emini E.A., and Shiver J.W. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 (2004) 2993
7. Greenberg H.B., and Piedra P.A. Immunization against viral respiratory disease: a review. Pediatr. Infect. Dis. J. 23 (2004) S254
8. Hannoun C., Megas F., and Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 103 (2004) 133
9. Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., and Bridges C.B. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 54 (2005) 1
10. Hsieh Y.C., Chen H.Y., Yen J.J., Liu D.P., Chang L.Y., Lu C.Y., Shao P.L., Lee C.Y., and Huang L.M. Influenza in Taiwan: seasonality and vaccine strain match. J. Microbiol. Immunol. Infect. 38 (2005) 238
11. Liu W., Zou P., Ding J., Lu Y., and Chen Y.H. Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design. Microbes Infect. 7 (2005) 171
12. O'Connell M., Belanger B.A., and Haaland P.D. The four parameter logistic model for calibration and assay development. American Statistical Association Proceedings of the Biopharmaceutical Section (1992) 180
13. Ray C.A., Bowsher R.R., Smith W.C., Devanarayan V., Willey M.B., Brandt J.T., and Dean R.A. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J. Pharm. Biomed. Anal. 36 (2005) 1037
14. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N. Engl. J. Med. 344 (2001) 889
15. Simonsen L., Fukuda K., Schonberger L.B., and Cox N.J. The impact of influenza epidemics on hospitalizations. J. Infect. Dis. 181 (2000) 831
16. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., and Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama 289 (2003) 179